MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Using Multi-Generational High-Risk Pedigrees to Identify Candidate Parkinson’s Disease Predisposition Genes

P. Moretti, K. Allen-Brady, J. Stevens, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, USA)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: To identify rare genetic variants associated with increased risk of Parkinson’s disease (PD) in multi-generational, high-risk pedigrees.

Background: Our current knowledge of PD genetics derives from two main approaches: the analysis of nuclear families carrying rare highly penetrant alleles, and GWAS. Using these methods, monogenic and polygenic PD risk factors have been identified, and together they account for 5-10% of familial and sporadic PD. It is estimated that an additional 20-25% of PD cases have a significant inherited component. We propose that studying high-risk, multi-generational pedigrees offers a powerful additional method for the identification of genetic variants affecting predisposition to PD.

Method: We identified pedigrees with high-risk of PD using the Utah Population Database (UPDB), a resource linking extensive genealogy information with medical record and other public health data sources. These pedigrees showed a statistically significant excess (p<0.05) of PD compared to the Utah population. Cases were identified by PD listed as a cause of death on death certificates. We performed whole exome sequencing (WES) on 16 PD cousin pairs and identified all rare (MAF<0.005), shared variants to identify candidate predisposition variants.  For validation we considered evidence for significant association with PD risk in Genebass, a resource of WES-based association statistics for a variety of phenotypes using UK Biobank data.

Results: We identified 278 pedigrees that included 2-10 sampled individuals with PD-related deaths.  From this group, we selected 28 high-risk clusters with significant excess of PD among pedigree members (p<0.05). We then selected the 16 pedigrees that also included one pair of first cousins with available DNA. WES and bioinformatics analysis of these PD-affected cousin pairs identified 242 rare, shared variants in 221 genes.  Of these, 4 variants in 4 unique genes (SLIT1, FOXD2, ADAMTSL5, and PRSS3) showed significant (p<0.05) association with PD risk in UK Biobank data.

Conclusion: WES in pairs of related sampled PD cases from high-risk multi-generational pedigrees led to the identification of shared DNA variants in 221 genes, 4 of which are found significant in UK Biobank data. Additional segregation studies of some of these candidate PD predisposition variants in these families are currently underway.

To cite this abstract in AMA style:

P. Moretti, K. Allen-Brady, J. Stevens, K. Figueroa, S. Pulst, L. Cannon-Albright. Using Multi-Generational High-Risk Pedigrees to Identify Candidate Parkinson’s Disease Predisposition Genes [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/using-multi-generational-high-risk-pedigrees-to-identify-candidate-parkinsons-disease-predisposition-genes/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/using-multi-generational-high-risk-pedigrees-to-identify-candidate-parkinsons-disease-predisposition-genes/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley